Rapamycin treatment causes developmental delay, pigmentation defects, and gastrointestinal malformation on Xenopus embryogenesis

Yuki Moriyama, Yoshihisa Ohata, Shoko Mori, Shinya Matsukawa, Tatsuo Michiue, Makoto Asashima, Hiroki Kuroda

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Rapamycin is a drug working as an inhibitor of the TOR (target of rapamycin) signaling pathway and influences various life phenomena such as cell growth, proliferation, and life span extension in eukaryote. However, the extent to which rapamycin controls early developmental events of amphibians remains to be understood. Here we report an examination of rapamycin effects during Xenopus early development, followed by a confirmation of suppression of TOR downstream kinase S6K by rapamycin treatment. First, we found that developmental speed was declined in dose-dependent manner of rapamycin. Second, black pigment spots located at dorsal and lateral skin in tadpoles were reduced by rapamycin treatment. Moreover, in tadpole stages severe gastrointestinal malformations were observed in rapamycin-treated embryos. Taken together with these results, we conclude that treatment of the drug rapamycin causes enormous influences on early developmental period.

Original languageEnglish
Pages (from-to)974-978
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume404
Issue number4
DOIs
Publication statusPublished - 2011 Jan 28
Externally publishedYes

Fingerprint

Pigmentation
Sirolimus
Xenopus
Embryonic Development
Defects
Larva
Cell growth
Amphibians
Life Expectancy
Eukaryota
Pigments
Pharmaceutical Preparations
Skin
Phosphotransferases
Embryonic Structures
Cell Proliferation

Keywords

  • Gastrointestinal malformation
  • Pigmentation
  • Rapamycin
  • TOR
  • Xenopus

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Rapamycin treatment causes developmental delay, pigmentation defects, and gastrointestinal malformation on Xenopus embryogenesis. / Moriyama, Yuki; Ohata, Yoshihisa; Mori, Shoko; Matsukawa, Shinya; Michiue, Tatsuo; Asashima, Makoto; Kuroda, Hiroki.

In: Biochemical and Biophysical Research Communications, Vol. 404, No. 4, 28.01.2011, p. 974-978.

Research output: Contribution to journalArticle

Moriyama, Yuki ; Ohata, Yoshihisa ; Mori, Shoko ; Matsukawa, Shinya ; Michiue, Tatsuo ; Asashima, Makoto ; Kuroda, Hiroki. / Rapamycin treatment causes developmental delay, pigmentation defects, and gastrointestinal malformation on Xenopus embryogenesis. In: Biochemical and Biophysical Research Communications. 2011 ; Vol. 404, No. 4. pp. 974-978.
@article{06293fe77ba94459be19b0f02666c7d7,
title = "Rapamycin treatment causes developmental delay, pigmentation defects, and gastrointestinal malformation on Xenopus embryogenesis",
abstract = "Rapamycin is a drug working as an inhibitor of the TOR (target of rapamycin) signaling pathway and influences various life phenomena such as cell growth, proliferation, and life span extension in eukaryote. However, the extent to which rapamycin controls early developmental events of amphibians remains to be understood. Here we report an examination of rapamycin effects during Xenopus early development, followed by a confirmation of suppression of TOR downstream kinase S6K by rapamycin treatment. First, we found that developmental speed was declined in dose-dependent manner of rapamycin. Second, black pigment spots located at dorsal and lateral skin in tadpoles were reduced by rapamycin treatment. Moreover, in tadpole stages severe gastrointestinal malformations were observed in rapamycin-treated embryos. Taken together with these results, we conclude that treatment of the drug rapamycin causes enormous influences on early developmental period.",
keywords = "Gastrointestinal malformation, Pigmentation, Rapamycin, TOR, Xenopus",
author = "Yuki Moriyama and Yoshihisa Ohata and Shoko Mori and Shinya Matsukawa and Tatsuo Michiue and Makoto Asashima and Hiroki Kuroda",
year = "2011",
month = "1",
day = "28",
doi = "10.1016/j.bbrc.2010.12.093",
language = "English",
volume = "404",
pages = "974--978",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Rapamycin treatment causes developmental delay, pigmentation defects, and gastrointestinal malformation on Xenopus embryogenesis

AU - Moriyama, Yuki

AU - Ohata, Yoshihisa

AU - Mori, Shoko

AU - Matsukawa, Shinya

AU - Michiue, Tatsuo

AU - Asashima, Makoto

AU - Kuroda, Hiroki

PY - 2011/1/28

Y1 - 2011/1/28

N2 - Rapamycin is a drug working as an inhibitor of the TOR (target of rapamycin) signaling pathway and influences various life phenomena such as cell growth, proliferation, and life span extension in eukaryote. However, the extent to which rapamycin controls early developmental events of amphibians remains to be understood. Here we report an examination of rapamycin effects during Xenopus early development, followed by a confirmation of suppression of TOR downstream kinase S6K by rapamycin treatment. First, we found that developmental speed was declined in dose-dependent manner of rapamycin. Second, black pigment spots located at dorsal and lateral skin in tadpoles were reduced by rapamycin treatment. Moreover, in tadpole stages severe gastrointestinal malformations were observed in rapamycin-treated embryos. Taken together with these results, we conclude that treatment of the drug rapamycin causes enormous influences on early developmental period.

AB - Rapamycin is a drug working as an inhibitor of the TOR (target of rapamycin) signaling pathway and influences various life phenomena such as cell growth, proliferation, and life span extension in eukaryote. However, the extent to which rapamycin controls early developmental events of amphibians remains to be understood. Here we report an examination of rapamycin effects during Xenopus early development, followed by a confirmation of suppression of TOR downstream kinase S6K by rapamycin treatment. First, we found that developmental speed was declined in dose-dependent manner of rapamycin. Second, black pigment spots located at dorsal and lateral skin in tadpoles were reduced by rapamycin treatment. Moreover, in tadpole stages severe gastrointestinal malformations were observed in rapamycin-treated embryos. Taken together with these results, we conclude that treatment of the drug rapamycin causes enormous influences on early developmental period.

KW - Gastrointestinal malformation

KW - Pigmentation

KW - Rapamycin

KW - TOR

KW - Xenopus

UR - http://www.scopus.com/inward/record.url?scp=79151481477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79151481477&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.12.093

DO - 10.1016/j.bbrc.2010.12.093

M3 - Article

VL - 404

SP - 974

EP - 978

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -